American Thoracic Society   Report issue

Foundation Phase 2 Phase 4
Founded: New York NY United States (1905)

Organization Overview

First Clinical Trial
2006
NCT00351533
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

American Thoracic Society

Active Ingredients

Drugs in Phase 4 Trials (1)

nicotine (nicorette) (1 trial)

Drugs in Phase 2 Trials (1)

fish oil (Omegavan) (1 trial)

Drugs in Other Trials (1)

acetylcysteine (mucomyst) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 2)

Lung Injury (Phase 2)

Respiratory Distress Syndrome (Phase 2)

Respiratory Distress Syndrome, Newborn (Phase 2)

Sarcoidosis (Phase 4)

Sarcoidosis, Pulmonary (Phase 4)

Syndrome (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3